Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: no.
Strauss
Martin H
MH
Clinical Cardiology, C-NET Research Group, LIGHT, Faculty of Medicine, University of Leeds, UK. Dr.Marty@bellnet.ca
Hall
Alistair
A
D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists; D002986:Clinical Trials as Topic; D006801:Humans; D020521:Stroke / Q000517:prevention & control*
D047228:Angiotensin II Type 1 Receptor Blockers; D057911:Angiotensin Receptor Antagonists